Company Data
Cognition Therapeutics Inc.
Ticker
CGTX
Current Price
$0.6096 -3.24%
Market Cap
$25.3M
Price Target
Refer to Report
Volume
1.3M
52wk Range
$0.34 - $2.95
Overview
Cognition Therapeutics Inc is a clinical-stage biopharmaceutical company engaged in the discovery and development of innovative, small molecule therapeutics targeting age-related degenerative diseases and disorders of the central nervous system and retina. Its lead product candidate, CT1812, is an orally delivered, small molecule antagonist designed to penetrate the blood-brain barrier and bind selectively to the S2R complex.